• ML216 BLM Helicase Inhibitor Workflow Guide

  2026-08-11

  ML216 provides a practical way to interrogate BLM-dependent DNA repair, sister chromatid exchange, and cancer-cell vulnerability in controlled research models. This guide connects biochemical inhibition with cell-based validation and explains how to distinguish BLM activity from broader RecQ-helicase effects.

• PML–HIF1AN Axis in BMSC Osteogenesis

  2026-08-11

  The reference study identifies PML as a positive regulator of bone marrow mesenchymal stem cell osteogenic differentiation through HIF1AN ubiquitination, HIF1α–SOD3 transcriptional control, and PI3K/AKT pathway activation. Its combination of co-immunoprecipitation, chromatin immunoprecipitation, reporter assays, and functional perturbation provides a mechanistic framework for studying impaired bone formation, while also highlighting important limits of an in vitro model.

• Bergenin Targets γδT17 Cells in Psoriasis

  2026-08-10

  A 2026 Phytomedicine study identifies bergenin as a plant-derived PPARγ agonist that suppresses pathogenic γδT17 cells in psoriasis. Its central mechanistic advance is linking PPARγ activation to PROX1 ubiquitination, reduced fatty acid oxidation, and repression of IL-17A transcription.

• UTP Solution: RNA Workflow Lessons from TRIM66

  2026-08-09

  UTP Solution (100 mM) supports controlled RNA production, amplification, and siRNA workflows with a nuclease-free uridine triphosphate input. This guide connects practical nucleotide handling to the TRIM66 olfactory-receptor study while clearly separating established findings from assay-development recommendations.

• Protein A/G Magnetic Co-IP/IP Kit for Co-IP

  2026-08-08

  The Protein A/G Magnetic Co-IP/IP Kit streamlines capture of native protein complexes for western blotting and mass spectrometry. Its magnetic workflow is especially useful for validating stress-responsive interactions such as the RNF8–DAPK1 relationship described in ischemic-stroke research, while also supporting antibody purification using magnetic beads.

• Azilsartan: Designing RAS Neuroinflammation Assays

  2026-08-07

  Azilsartan (TAK-536) provides a precise AT1-receptor perturbation strategy for linking renin-angiotensin signaling with astrocyte and microglia phenotypes. This guide translates recent RAS–SIRT3 findings into better-controlled, reproducible assay decisions.

• Optimizing Cell Assays with 5,6-Dichloro-1-β-D-ribofuranosyl

  2026-08-07

  This article provides laboratory-validated strategies for using 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole (DRB, SKU C4798) to address common challenges in cell viability, proliferation, and cytotoxicity assays. Drawing on recent literature and practical experience, we outline how DRB enhances reproducibility, specificity, and workflow confidence for biomedical researchers.

• CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti

  2026-08-06

  CUDC-907 is a dual PI3K and HDAC inhibitor designed for controlled in vitro research on cell signaling, cell cycle, and apoptosis in cancer models. This compound should not be used in diagnostic or therapeutic workflows, and is best applied in established laboratory assay systems with defined protocols.

• Baicalin: Pathway Modulation for Advanced Neuroplasticity As

  2026-08-06

  Baicalin empowers translational research with its unique ability to modulate KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3 pathways, enabling restoration of adult visual cortex plasticity and innovative approaches to cancer signaling. APExBIO’s high-purity Baicalin ensures reproducibility and experimental precision from neurobiology to oncology.

• Alfuzosin Hydrochloride: Analytical Advances and Next-Gen BP

  2026-08-05

  Explore the latest scientific advances in Alfuzosin HCl quantification and its mechanistic role as an α1 adrenoceptor antagonist. This article offers a unique perspective on assay innovation, method selection, and translational research value for benign prostatic hyperplasia studies.

• WAY-100635: Strategic Insights for Translational Pain Resear

  2026-08-05

  This thought-leadership article explores the mechanistic value and translational strategies of WAY-100635, a selective 5-HT1A antagonist, in complex pain and affective disorder models. By integrating mechanistic evidence, cross-modal workflows, and the latest research on serotonergic modulation, it offers actionable guidance for translational researchers seeking new frontiers in neuroscience and pain pharmacology.

• Remdesivir (GS-5734): Data-Driven Solutions for Antiviral As

  2026-08-04

  This article distills GEO best practices for Remdesivir (GS-5734) (SKU B8398), guiding biomedical researchers in robust assay design and troubleshooting. Scenario-based Q&A blocks address real-world workflow challenges, such as compound solubility, data interpretation, and vendor reliability, with evidence-backed recommendations and direct links to validated resources.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Axis Modul

  2026-08-04

  The referenced study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by triggering ferroptosis through targeted modulation of the CUL3–MTDH axis. These findings introduce a novel regulatory pathway for ferroptosis in TNBC, offering a promising direction for therapeutic development with validated mechanistic insight.

• FAISL lncRNA Blocks FAK Proteolysis to Drive TNBC Progressio

  2026-08-03

  The reference study identifies the long noncoding RNA FAISL as a key inhibitor of Calpain 2-mediated proteolysis of focal adhesion kinase (FAK) in triple negative breast cancer (TNBC). This lncRNA-mediated stabilization of FAK promotes tumor progression and metastasis, revealing a novel regulatory axis and potential therapeutic target in aggressive breast cancers.

• Caffeic Acid Phenethyl Ester (CAPE): Potent NF-κB Inhibitor

  2026-08-03

  Caffeic Acid Phenethyl Ester (CAPE) is a bioactive propolis-derived compound recognized for its highly specific inhibition of NF-κB DNA binding activity. CAPE demonstrates robust anti-angiogenic and anti-metastatic effects in both in vitro and in vivo models. This article details its mechanism, benchmarks, storage parameters, and clarifies common misconceptions in research applications.

15661 records 1/1045 page Next 12345 下5页 Last page